Rational design of a novel rapid diagnostic tool for coccidioidomycosis
合理设计新型球孢子菌病快速诊断工具
基本信息
- 批准号:10668184
- 负责人:
- 金额:$ 25.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-23 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAnimalsAnti-Bacterial AgentsAntibodiesAntifungal AgentsAntigensAreaBioinformaticsBiologicalBiological AssayBiological MarkersBiosensorBloodCenters for Disease Control and Prevention (U.S.)Central AmericaClinicalClinical TrialsCoccidioidesCoccidioides immitisCoccidioides posadasiiCoccidioidomycosisCoupledDataData AnalysesDependenceDetectionDevelopmentDiagnosisDiagnosticDiagnostic testsDiseaseEngineeringEscherichia coliEvaluationFiltrationFutureGene ProteinsGenesGenomicsGoalsHarvestHealth Care CostsHumanHydrocortisoneImageryImmune responseIn VitroIncidenceIndustryInfectionIntellectual PropertyLaboratoriesLength of StayMarketingMethodologyMethodsMolecularMusMycosesOutcome StudyPatient-Focused OutcomesPatientsPerformancePhasePolymersProcessProtein SecretionProteinsProviderRapid diagnosticsRecombinant ProteinsRecombinantsReportingReproducibilityResearchResource-limited settingSamplingSerodiagnosesSerumSoilSouth AmericaSouthwestern United StatesSpecificityStructure of parenchyma of lungSymptomsSystemTechniquesTestingTranscriptUnited StatesUp-RegulationValidationaccurate diagnosisantibody testantigen diagnosticantigen testbacterial communitybioelectronicsbiomarker validationcandidate selectioncommunity acquired pneumoniacostdesert feverdesigndetection limitdiagnostic assaydiagnostic tooleffective therapyexperimental studyfungusgenomic dataimprintimprovedin silicoin vivoinnovationinterdisciplinary approachmanufacturemodel organismnovelnovel diagnosticsnovel strategiespathogenic fungusperipheral bloodradiological imagingrapid diagnosisrational designreagent testingscreeningsensorstatisticssynthetic antibodiessynthetic biologytime usetranscriptome sequencing
项目摘要
Coccidioides immitis and C. posadasii are two species of soil fungi that cause the disease coccidioidomycosis,
(or Valley fever), whose incidence has increased 587% over the last 20 years and now causes over 150,000
new infections in the United States annually. The Centers for Disease Control and Prevention (CDC) report that
average cost for treating Valley fever is over $50,000 per patient and delays or misdiagnosis of Valley fever
result in an average of $590,000 in extra healthcare costs, including extensive hospital stays and a lifetime of
treatment. Current Valley fever diagnostic tests are based on proprietary antibodies or antigens, which may not
be easily accessed. We propose that advanced genomic analyses of these fungal pathogens can support the
identification of new biomarkers and embody the foundational framework that is necessary for development of
new diagnostic tools. We aim to improve the diagnostics available for detection of Coccidioides spp. by analyzing
existing genomic data and using in silico predictions to identify several putative antigens that are highly
expressed during host infection and would likely interact with the host. We will express these novel antigens
along with standard control CF and TP antigens from Coccidioides in a model organism (Escherichia coli) and
use the protein products to create an electrochemical sensor Molecularly Imprinted Polymer (MIP) diagnostic
assay. MIPs are a polymer that has been processed using a molecular imprinting technique which leaves cavities
in the polymer matrix with high affinity for a chosen ‘template’ molecule (in our case the antigens expressed by
E. coli). When paired with an electrochemical biosensor, MIPs can be the basis for a low-cost diagnostic tool
because they mimic biological recognition well enough to be called ‘synthetic antibodies.’ In total, this proposal
represents a unique pairing of advanced genomic data analysis and novel diagnostic development in an
important, yet understudied, fungal pathogen.
Coccidioides immitis 和 C. posadasii 是引起球孢子菌病的两种土壤真菌,
(或谷热),其发病率在过去 20 年中增加了 587%,目前已导致超过 150,000 人死亡
美国疾病控制与预防中心 (CDC) 每年都会报告新感染病例。
治疗山谷热的平均费用为每位患者超过 50,000 美元,并且山谷热的延误或误诊
平均导致 590,000 美元的额外医疗费用,包括长期住院和终生
目前的谷热诊断测试基于专有抗体或抗原,但可能并非如此。
我们建议对这些真菌病原体进行先进的基因组分析可以支持
识别新的生物标志物并体现开发所需的基础框架
我们的目标是通过分析来改进可用于检测球孢子菌的诊断方法。
现有的基因组数据并使用计算机预测来识别几种高度可靠的推定抗原
在宿主感染期间表达并可能与宿主相互作用。我们将表达这些新抗原。
以及模型生物体(大肠杆菌)中球孢子菌的标准对照 CF 和 TP 抗原以及
使用蛋白质产品创建电化学传感器 分子印迹聚合物 (MIP) 诊断
MIP 是一种使用分子印迹技术加工而成的聚合物,会留下空腔。
在聚合物基质中对选定的“模板”分子具有高亲和力(在我们的例子中,抗原表达为
当与电化学生物传感器配合使用时,MIP 可以成为低成本诊断工具的基础。
因为它们很好地模仿了生物识别,可以被称为“合成抗体”。总的来说,这个提议
代表了先进的基因组数据分析和新颖的诊断开发的独特组合
重要但尚未得到充分研究的真菌病原体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bridget Marie Barker其他文献
Bridget Marie Barker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bridget Marie Barker', 18)}}的其他基金
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10356627 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10356628 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10689668 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10689675 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Functional Analysis of Regions of Introgression Between Species of Coccidioides
球孢子菌种间基因渗入区域的功能分析
- 批准号:
8487708 - 财政年份:2014
- 资助金额:
$ 25.6万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
Fosl2调控染色质开放性在哺乳动物卵丘-卵母细胞复合物成熟过程中的机制研究
- 批准号:82301863
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
H5亚型禽流感病毒PA蛋白诱导降解JAK1增强病毒对哺乳动物致病性的作用及机制研究
- 批准号:32373042
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
动物双歧杆菌对不同聚合度低聚木糖同化差异性的分子机制研究
- 批准号:32302789
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
相似海外基金
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
- 批准号:
10603486 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
Ribosome structure determination from Apicomplexan parasites
顶复门寄生虫的核糖体结构测定
- 批准号:
10726704 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别: